Atrium Therapeutics, Inc.
NASDAQ:RNABiotechnology
+$0.16 today
- Market cap
- $143.23M
- Beta
- 0.42
- P/E (TTM)
- -3.3
- EPS (TTM)
- -$3.78
Volume 0.22M
Average 0.35M
RNA Acquisitions (Net)
Cash paid for acquiring businesses, net of cash acquired.
Atrium Therapeutics, Inc.NASDAQ: RNA
Acquisitions (Net) · Q1 FY2026 · quarter ended Mar 2026
Acquisitions (net) of $0 in Q1 FY2026
Q1 FY2026 acquisitions (net) was $0.
Context
- Acquisitions (net) amounted to 0.0% of revenue in FY2025.
Sources:Cash FlowText generated from reported figures; not investment advice.
Acquisitions (Net) history
USD · from the cash flow
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Acquisitions (Net) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
Acquisitions (Net) vs competitors
How RNA compares with its peers on the latest reported figures
No competitor Acquisitions (Net) figures are available to compare.
Cash Flow Statement
Atrium Therapeutics, Inc.
NASDAQ:RNA
Intrinsic Alpha fair value
Locked
Current Price
$6.64
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.